跳到正文
Recursion· @RecursionPharma · X·· 27 天前AI 评分21
AI 导读

Recursion 将候选分子从计算设计直接送入自动化 DMTL 实验室,并由内部 AI 智能体辅助规划合成路线。平台可规模化执行复杂多步药物化学,自动完成 workup、纯化和数千化合物的数字样本追踪。设计、制造、测试全生命周期在同一集成系统中闭环,消除团队间数据交接的摩擦和时间损失。

正文 · 原文

"This is only possible because we control the design, make, and test steps within one connected system rather than handing off between disconnected tools and teams."

Once molecules are designed in silico, they must be synthesized and tested in the real world. In Part 7 of our platform series, VP of Pharmacology Martin Redhead, Ph.D., explains how these candidate designs move directly into our automated DMTL (Design, Make, Test, Learn) labs.

Recursion’s automated chemistry platform goes far beyond simple one-pot reactions. We execute complex, multi-step medicinal chemistry at scale. Advanced automation handles the workup, purification, and digital sample tracking for thousands of compounds, creating a digital record of every single experiment.

Our in-house AI agents take this a step further by actively helping scientists plan efficient synthetic routes. Because we control the entire design, make, and test lifecycle within one fully integrated system, we completely eliminate the friction and time lost handing off data between disconnected teams.

🚀 Follow along over the coming weeks as we continue this series, covering how Recursion maps biology, optimizes precision drug design, and closes the gap between patient and discovery.

#TechBio #DrugDesign #ComputationalChemistry #DrugDiscovery #MachineLearning

来源:Recursion · x.com